Alongside the guidance update, HHS plans to study biological mechanisms and possible links that may contribute to autism.

BOTHELL, Wash., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30, 2025, ...

Hepatitis B vaccines given at birth have essentially eliminated the disease in kids. A vote this week could upend that ...

A combination treatment involving tobevibart and elebsiran significantly improved disease activity in adults with chronic ...

Chronic HBV infection remains a major global health burden, with current antiviral therapies effectively suppressing viral ...

Delaying the timing of vaccinating infants against hepatitis B — which ACIP could vote on later this week — would likely lead ...

When cells proliferate, genomic DNA is precisely duplicated once per cell cycle. Abnormalities in this DNA replication ...

Both tobevibart (a monoclonal antibody) and elebsiran (a small interfering RNA) target hepatitis B virus surface antigen (HBsAg). Their efficacy and safety in the treatment of chronic hepatitis D ...

The Vaccine Integrity Project’s evidence review of the first dose of the hepatitis B vaccine will offer a transparent, ...

WASHINGTON -- An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial. At week 24, the ...